191 related articles for article (PubMed ID: 25548141)
1. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
[TBL] [Abstract][Full Text] [Related]
2. Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
Shimizu M; Ishikawa J; Yano Y; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K
J Hypertens; 2012 May; 30(5):1015-21. PubMed ID: 22406464
[TBL] [Abstract][Full Text] [Related]
3. Nighttime home blood pressure and the risk of hypertensive target organ damage.
Ishikawa J; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K;
Hypertension; 2012 Oct; 60(4):921-8. PubMed ID: 22892810
[TBL] [Abstract][Full Text] [Related]
4. Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment?
Hoshide S; Yano Y; Shimizu M; Eguchi K; Ishikawa J; Kario K
Hypertens Res; 2012 Aug; 35(8):862-6. PubMed ID: 22476230
[TBL] [Abstract][Full Text] [Related]
5. Association between home arterial stiffness index and target organ damage in hypertension: comparison with pulse wave velocity and augmentation index.
Matsui Y; Ishikawa J; Shibasaki S; Shimada K; Kario K
Atherosclerosis; 2011 Dec; 219(2):637-42. PubMed ID: 21978919
[TBL] [Abstract][Full Text] [Related]
6. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study.
Hoshide S; Kario K; Yano Y; Haimoto H; Yamagiwa K; Uchiba K; Nagasaka S; Matsui Y; Nakamura A; Fukutomi M; Eguchi K; Ishikawa J;
Am J Hypertens; 2014 Jul; 27(7):939-47. PubMed ID: 24473255
[TBL] [Abstract][Full Text] [Related]
7. Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.
Fujiwara T; Yano Y; Hoshide S; Kanegae H; Hashimoto J; Kario K
Am J Hypertens; 2018 Aug; 31(9):995-1001. PubMed ID: 29850782
[TBL] [Abstract][Full Text] [Related]
8. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
Kario K; Hoshide S; Shimizu M; Yano Y; Eguchi K; Ishikawa J; Ishikawa S; Shimada K
J Hypertens; 2010 Jul; 28(7):1574-83. PubMed ID: 20404743
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
[TBL] [Abstract][Full Text] [Related]
10. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension.
Matsui Y; Ishikawa J; Eguchi K; Shibasaki S; Shimada K; Kario K
Hypertension; 2011 Jun; 57(6):1087-93. PubMed ID: 21536993
[TBL] [Abstract][Full Text] [Related]
11. A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study. Losartan Intervention For Endpoint reduction.
Olsen MH; Wachtell K; Borch-Johnsen K; Okin PM; Kjeldsen SE; Dahlöf B; Devereux RB; Ibsen H
J Hum Hypertens; 2002 Aug; 16(8):591-5. PubMed ID: 12149666
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of antihypertensive therapy for reduction in left ventricular mass.
Hashimoto J; Imai Y; O'Rourke MF
Am J Hypertens; 2007 Nov; 20(11):1229-33. PubMed ID: 17954372
[TBL] [Abstract][Full Text] [Related]
13. A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.
Eguchi K; Hoshide S; Komori T; Nagasaka S; Kario K
Am J Hypertens; 2015 Aug; 28(8):971-9. PubMed ID: 25528450
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
[TBL] [Abstract][Full Text] [Related]
15. Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge-1 study.
Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Shimada K; Kario K;
J Hypertens; 2010 Aug; 28(8):1752-60. PubMed ID: 20485195
[TBL] [Abstract][Full Text] [Related]
16. Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects.
Spratt JC; Webb DJ; Shiels A; Williams B
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):227-32. PubMed ID: 11881128
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
19. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication.
Shibuya Y; Ikeda T; Gomi T
Hypertens Res; 2007 Oct; 30(10):903-11. PubMed ID: 18049021
[TBL] [Abstract][Full Text] [Related]
20. Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
Hosaka M; Inoue R; Satoh M; Watabe D; Hanazawa T; Ohkubo T; Asayama K; Obara T; Imai Y;
Clin Exp Hypertens; 2018; 40(5):468-475. PubMed ID: 29172732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
